Home
Mail
News
Finance
Sports
Entertainment
Search
Mobile
More...
Yahoo Finance
Search
Skip to Navigation
Skip to Main Content
Skip to Related Content
Sign in
Mail
Sign in
to view your mail
Watchlists
My Portfolio
Markets
News
Videos
Yahoo Finance Plus
Screeners
Personal Finance
Crypto
Sectors
Contact Us
Advertisement
U.S. markets open in 2 hours 28 minutes
S&P Futures
5,306.50
-1.75
(-0.03%)
Dow Futures
40,148.00
+4.00
(+0.01%)
Nasdaq Futures
18,494.50
-9.25
(-0.05%)
Russell 2000 Futures
2,138.10
-0.30
(-0.01%)
Crude Oil
82.18
+0.83
(+1.02%)
Gold
2,232.90
+20.20
(+0.91%)
Urologix, Inc. (ULGX)
Other OTC - Other OTC Delayed Price. Currency in USD
Follow
0.0001
0.0000
(0.00%)
At close: 10:48AM EDT
Summary
Company Insights
Chart
Conversations
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
Advertisement
Show
:
Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
Upgrade to begin using 40 years of financial statements and get so much more.
Download
Income Statement
Expand All
All numbers in thousands
Upgrade to begin using 40 years of financial statements and get so much more.
Learn more
Breakdown
ttm
Total Revenue
12,190
Cost of Revenue
6,370
Gross Profit
5,820
Operating Expense
6,720
Operating Income
-900
Net Non Operating Interest Income Expense
-771
Other Income Expense
-3,050
Pretax Income
-4,721
Tax Provision
-53
Net Income Common Stockholders
-4,668
Diluted NI Available to Com Stockholders
-4,668
Basic EPS
-0.22
Diluted EPS
-0.22
Basic Average Shares
21,599
Diluted Average Shares
21,599
Total Operating Income as Reported
-3,936
Total Expenses
13,090
Net Income from Continuing & Discontinued Operation
-4,668
Normalized Income
-1,652
Net Interest Income
-771
EBIT
-1,018
EBITDA
-517
Reconciled Cost of Revenue
5,948
Reconciled Depreciation
501
Net Income from Continuing Operation Net Minority Interest
-4,668
Total Unusual Items Excluding Goodwill
-3,050
Total Unusual Items
-3,050
Normalized EBITDA
2,533
Tax Rate for Calcs
0
Tax Effect of Unusual Items
-34.2406
Yahoo Finance Plus Essential access required.
Learn more
Advertisement
Advertisement
Data Disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Your Privacy Choices
About Our Ads
Sitemap
© 2024 Yahoo. All rights reserved.